These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34519496)

  • 1. Drug-to-Antibody Ratio Estimation via Proteoform Peak Integration in the Analysis of Antibody-Oligonucleotide Conjugates with Orbitrap Fourier Transform Mass Spectrometry.
    Nagornov KO; Gasilova N; Kozhinov AN; Virta P; Holm P; Menin L; Nesatyy VJ; Tsybin YO
    Anal Chem; 2021 Sep; 93(38):12930-12937. PubMed ID: 34519496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
    Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
    J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Uranium Isotope Ratio Analysis in Liquid Sampling-Atmospheric Pressure Glow Discharge/Orbitrap FTMS Coupling through the Use of an External Data Acquisition System.
    Bills JR; Nagornov KO; Kozhinov AN; Williams TJ; Tsybin YO; Marcus RK
    J Am Soc Mass Spectrom; 2021 May; 32(5):1224-1236. PubMed ID: 33793219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
    Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control.
    Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W
    Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
    Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
    Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Mass Analysis with a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer: From Inorganic Salt Clusters to Antibody Conjugates and Beyond.
    Campuzano IDG; Nshanian M; Spahr C; Lantz C; Netirojjanakul C; Li H; Wongkongkathep P; Wolff JJ; Loo JA
    J Am Soc Mass Spectrom; 2020 May; 31(5):1155-1162. PubMed ID: 32196330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-to-antibody ratio (DAR) and drug load distribution by LC-ESI-MS.
    Basa L
    Methods Mol Biol; 2013; 1045():285-93. PubMed ID: 23913155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
    Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
    Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
    Ouyang J
    Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoprecipitation middle-up LC-MS for in vivo drug-to-antibody ratio determination for antibody-drug conjugates.
    Davis JA; Kagan M; Read J; Walles M; Hatsis P
    Bioanalysis; 2017 Oct; 9(20):1535-1549. PubMed ID: 29072490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels.
    Jones J; Pack L; Hunter JH; Valliere-Douglass JF
    MAbs; 2020; 12(1):1682895. PubMed ID: 31769727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
    Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
    MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.
    Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G
    J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
    Källsten M; Pijnappel M; Hartmann R; Lehmann F; Kovac L; Lind SB; Bergquist J
    Anal Bioanal Chem; 2019 May; 411(12):2569-2576. PubMed ID: 30848315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
    Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
    Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.